Clinical trial
Transarterial Ethanol Ablation (TEA) Versus Transcatheter Arterial…
NCT00467974 · Chinese University of Hong Kong, Other · Completed
Key facts
| NCT number | NCT00467974 |
|---|---|
| Title | Transarterial Ethanol Ablation (TEA) Versus Transcatheter Arterial Chemoembolisation (TACE) for Hepatocellular Carcinoma |
| Official title | A Randomized Controlled Trial of Transarterial Ethanol Ablation (TEA) With Lipiodol-Ethanol Mixture (LEM) Versus Transcatheter Arterial Chemoembolisation (TACE) for Unresectable Hepatocellular Carcinoma |
| Lead sponsor | Chinese University of Hong Kong, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatocellular Carcinoma |
| Intervention type | Procedure |
| Interventions | TEA with LEM, TACE |
| Enrollment | 98 |
| Start date | Jun 1, 2007 |
| Primary completion | Nov 1, 2014 |
| Completion | Nov 1, 2014 |
| First posted | May 1, 2007 |
| Last update posted | Jan 26, 2015 |
| Countries | Hong Kong |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: